论文部分内容阅读
观察Enalapril对CHF患者血清类洋地黄因子的影响。结果表明,应用Enalapril后,患者心功能均有不同程度的改善(P<0.01),类洋地黄因子水平从0.21±0.06μg/L升至0.46±0.09μg/L(P<0.05);而对照组的心功能和类洋地黄因子浓度均无改变(P>0.05)。提示Enalapril的治疗机理之一可能是促进类洋地黄因子的释放。
To observe the effect of Enalapril on digitalis in CHF patients. The results showed that the heart function of Enalapril group was improved to some extent (P <0.01), the digitalis-like factor level increased from 0.21 ± 0.06μg / L to 0.46 ± 0.09μg / L (P <0.05) The cardiac function and the concentration of digitalis did not change (P> 0.05). It is suggested that one of the therapeutic mechanisms of Enalapril may be to promote the release of digitalis.